Skip to main content
Sandy Jean-Baptiste on Muck Rack

Sandy Jean-Baptiste

As seen in: Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sandy

Contact Sandy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors

|
By Benoît Roch, Sandy Jean-Baptiste, Amandine Coffy, Estelle Palaysi
| Lung Cancer Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 Kaplan-Meier estimates of survival of non-small cell lung patients receiving anti-PD-1 immune-checkpoint inhibitors, according to body-weight loss in the three previous months; a: progression-free survival; b: overall survival. Fig.
Open in Who Shared Issue with article?

Synchronous multiple non-small cell lung cancers in an allograftlung recipient

|
By Jean-Louis Pujol, Unité d’oncologie Thoracique, Sandy Jean-Baptiste
| Lung Cancer Verified
Publication HistoryPublished online: July 19, 2018Accepted: July 18, 2018; Received in revised form: July 9, 2018; Received: April 13, 2018;
Open in Who Shared Issue with article?
See all 2 articles